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New antibiotics against multidrug-resistant bacteria are urgently needed, but rapid 
acquisition of resistance limits their usefulness. Endogenous antimicrobial peptides 
(AMPs) with moderate selectivity, but multimodal mechanism of action, have remained 
effective against bacteria for millions of years. Their therapeutic application, however, 
requires optimizing the balance between antibacterial activity and selectivity, so that 
rational design methods for increasing selectivity are highly desirable. We have created 
training (n=36) and testing (n=37) sets from frog-derived AMPs with determined 
therapeutic index (TI). The ‘sequence moments’ concept then enabled us to find a one-
parameter linear model resulting in a good correlation between measured and predicted 
TI (r2=0.83 and 0.64 for each set, respectively). The concept was then used in the AMP-
Designer algorithm to propose primary structures for highly selective AMPs against 
Gram-negative bacteria. Testing the activity of one such peptide produced a TI>200 as 
compared to the best AMP in the data-base, with TI=125. 
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All higher organisms produce cationic antimicrobial peptides (AMPs)1 whose main 
targets of action are membranes and associated biological functions2.  Bacteria cannot easily 
reorganize, nor can they markedly alter, their lipid composition or their requirement for a 
strong, inside-directed electric field (attracting cations). For these reasons, AMPs have a low 
tendency to elicit resistance and show a moderate selectivity for bacterial cells.  
A large group of AMPs acquire an amphipathic α-helical secondary structure in a low 
dielectric constant environment, such as when they interact with the cytoplasmic membrane3, 
but in most cases their primary structure has not been related with quantitative parameters 
expressing their activity against either bacterial or host cells. Even when structural parameters 
affecting activity are known, it is a challenge to maintain or increase antibacterial activity 
while simultaneously decreasing hemolytic activity, since some optimal combination of 
specific attributes must be reached4. Increasing peptide selectivity requires a better definition 
of those structural features of AMPs which have evolved to ensure a selective action in 
fending off microbes without endangering host cells.  
We have created an AMP activity database (AMPad) of 73 frog-derived AMPs with 
propensity to form amphipathic helices in membrane-mimetic solvents, which connects 
measured peptide selectivity with associated primary structures (Supplementary Tables S1 
and S2). Published results were selected only where antimicrobial activity was determined by 
the serial dilution method, in terms of the minimal inhibitory concentration (MIC) towards  E. 
coli, and cytotoxicity expressed in terms of 50% hemolysis of fresh human blood cells (HC50). 
The therapeutic index (TI), a measure of peptide selectivity, is then defined as: TI = 
HC50/MIC. To extract rules as general as possible we have then divided the AMPad database 
in a training data set of 36 non-homologous (less than 70% pair-wise identity) peptides and a 
test data set of the 37 remaining peptides. All but two peptides (pexiganan and gaegurin 4 
W16) in the training set were of natural origin.  
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Our first goal was to find a one-parameter linear model for correlating measured and 
predicted TI values. To the best of our knowledge, non-homologous antimicrobial peptides 
have never been used before in quantitative structure-activity studies of TI. Furthermore, most 
structure-activity studies of AMPs used multi-linear models for predicting peptide activity5. 
Models with only one peptide descriptor were not expected to work, due to the well know 
necessity to use several interrelated structural and physicochemical parameters that all 
modulate activity and specificity, such as charge, secondary structure, amphipathicity, and 
hydrophobicity3.  
A different approach is however possible, which does not use peptide mean properties 
as given descriptors, but instead exploits the observation4,6 that position-dependent 
physicochemical properties also determine peptide activity and selectivity. Position-dependent 
amino acid attributes are usually represented as smoothed, two-dimensional sequence profiles, 
such as the Kyte-Doolittle hydrophobicity profile. To simplify analyses, the whole sequence 
profile for chosen amino acid attributes can be converted into one vector with two 
components (x and y). This can be easily done by bending the sequence in, for instance, a 
right angle arc, and then performing vector summation of attribute vectors associated with all 
amino acids in the sequence (Figure 1). A vector sum that replaces the sequence profile will 
be named the sequence moment. Unlike a peptide’s amphipathicity, which is quantified by 
Eisenberg’s hydrophobic moment7, the sequence moment does not depend on knowledge of 
the secondary structure, but rather is an indicator of peptide lengthwise asymmetry.  
Amino acid attribute profiles were obtained by selecting 144 amino acid scales used to 
study integral membrane proteins and protein folding 8-10. The simplest methods for finding 
sequence profiles were then: a) direct usage of amino acid attributes, or b) smoothed amino 
acid attributes associated with a central amino acid in a sliding window either considering all 
residues in the window (mean values) or without taking into account the attribute of the 
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central amino acid itself (sequence environment values). Using any one of the selected 144 
scales to derive scalars from the corresponding sequence moments, we could not however 
achieve the desired high correlation among these descriptors and measured TI. The next 
simplest choice was to use sequence moments for two different amino acid scales and to 
examine for which pair any given scalar descriptor, derived from the two sequence moments, 
will give the desired high correlation.  
The simplest parameter thus obtained, providing a correlation 2r  = 0.83 with 
measured TIs from the training data set, was named the D descriptor (Methods). It is the 
cosine of the angle between sequence moments calculated from sequence environments when 
Janin’s11 and Guy's hydrophobicity scales12 are used. These scales are somewhat correlated ( 
r2 = 0.64). Janin’s scale was obtained by calculating the ratio of buried to accessible molar 
fractions of each amino acid in soluble proteins, while Guy’s scale followed from calculating 
residue transfer free-energy from the surface to the center of soluble proteins. After 
calculating the D descriptor values for training set peptides the predicted TI is found as the 
best linear fit: 50.126 44.803TI D= −  (Supplementary Figure S1). The correlation 
between measured and predicted TI so obtained for the test set of peptides is then expressed 
as a determination coefficient, 2R  = 0.64, which is still an acceptable indication that a 
correlation exists (Supplementary Figure S2). Figure 1 illustrates that angular separation of 
sequence moments is quite different for a highly selective (PGLa)(Supplementary Method 
1) and a mediocre peptide antibiotic (pseudin 2).  Notice that peptide lengthwise asymmetry is 
additionally strengthened by modeling the observation that amino acids closer to N-terminus 
are more relevant for peptide activity3,13. 
The D descriptor then helped us in our second goal; to create an algorithm capable of 
proposing novel peptides with a potentially high therapeutic index. The number of possible 
peptides, even when we restrict ourselves to a 23 amino acid length, is however extremely 
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large. We used a recursive algorithm and imposed various rational restrictions to reduce these 
to a workable number of potential AMP candidates with a high TI (see Methods,  
Supplementary Method 2 and Supplementary Tables S3-S5).  
General requirements included i) mean hydrophobicity values according to the CCS 
scale within an allowed range,3, 14  ii) predicted TI values of at least 85, and iii) limiting design 
to amphipathic helix-forming peptides. A statistical analysis of the most common motifs and 
amino acids associated with the set of best peptides led to the remaining set of restrictions out 
of which the motif regularity index is probably the most important innovation. 
As a result, the AMP-Designer algorithm produced the 7 peptides (out of 298 10≈ ⋅  
possibilities, see Methods). Six of these end with a cysteine residue, which may be a vestige 
from the so called “Rana-box”, a cysteine-bridged stretch present at the C-terminus of many 
frog-derived helical antimicrobial peptides3,15, which is not correlated with increased activity 
or selectivity15. Hence, we considered the best candidate for synthesis and characterization to 
be the seventh: GIGKHVGKALKGLKGLLKGLGES  (DESC 1), with a predicted TI =  
86, mean hydrophobicity14  H = -1.0, and a relative amphipathicity16 of  0.66 (66% that of a 
perfectly amphipathic peptide). The underlined “small” motifs [A,G,S]XXX[A,G,S] promote 
helix-helix interaction in the membrane17.  Neglecting the requirement that the predicted TI be 
higher than 85 (ie. D descriptor omission), would have lead to a total of 37 designed peptides, 
indicating that using the D descriptor was useful in eliminating 81% of these peptides.  
The suggested peptide was synthesized in good purity (Supplementary Figure S3), 
together with two known frog peptides from the training database. Ascaphin 1 and pseudin 2 
were selected as controls because we hoped that observed structural and functional properties 
of DESC1 would span the range of corresponding peptide attributes for good and mediocre 
peptide antibiotics. This was indeed the case for most attributes (see Supplementary Figure 
S4 and Supplementary Table S6). For instance, despite the presence of numerous glycine 
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residues, DESC1 has an estimated helical content of about 70% in the presence of the helix 
promoting solvent TFE. 
Antimicrobial activity assays confirmed that the DESC 1 is selectively active against 
Gram-negative bacteria (Table 1). Its C-terminally amidated form had a MIC value of 2-4 μM 
against E. coli, against which it was designed, and a moderate activity also towards P. 
aeruginosa, whereas its activity is poor against the Gram-positive bacterium S. aureus.  The 
designed peptide did not quite reach 50% lysis of red blood cells even at the highest 
concentration tested; 800 μM (Table 1 and Figure 2). By comparison, pseudin showed a 
HC50 of 50 μM under the same conditions, and ascaphin of 80 μM. Using these data to 
determine experimental TI values, and comparing them with predicted TI, we found values 
for control peptides of 6 against the predicted 8 for pseudin, 39 against the predicted 55 for 
ascaphin (Table 1 and Supplementary Table S1). These data, together with those for DESC 
1, with a measured TI value of over 200 against the predicted 86, more than confirm the 
design method.  
The high selectivity of the designed peptide DESC1 may in part derive from its 
unusual primary structure, which contains seven glycine residues, and which is ≤ 50% 
identical to any known helical AMP, being closest to bombinin (BMN_BOMVA, accession 
P01505, 50% identity). Based on a statistical analysis of natural helical AMPs3, glycine 
residues have an increased frequency at position 7 or 14. It was shown that placing a Gly 
residue at position 7 in a 19mer artificial helical AMP18, somewhat increased selectivity, 
while placing Gly in position 14, or 7 and 14 considerably reduced antimicrobial potency, so 
there seemed to be positional requirements for its use in increasing selectivity. Using the D 
descriptor in connection with the AMP-Designer algorithm it was possible to simultaneously 
introduce 6 internal glycine residues without markedly reducing activity towards Gram-
negative microorganisms, while dramatically increasing selectivity.   
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The flexibility of the DESC1 peptide and its Gly distribution pattern may have the 
dual role of facilitating unstructured monomers to pass easily through cell wall components19 
and of increasing the probability of transient monomer aggregation and pore formation at the 
level of the cytoplasmic membrane. Being different from any known AMP, the DESC1 
peptide can be considered as the first member of new glycine-rich class of helical AMP lead 
compounds for potential medical applications.  
Our method offers rational peptide design for maximizing target selectivity (against 
Gram-negative bacteria) that does not depend on homology to known structures as a main 
bottleneck for designing new structures. Its strength is that it depends on multiple flexible 
screening criteria. For example, a D-descriptor close to -1.0 is only one indicator that predicts 
that a TI can be high.  However, an all-Gly peptide would also have maximal predicted TI by 
just this criterion, because with the chosen pair of amino acid scales (Guy’s and Janin’s) all 
sequence environments are then of opposite sign. This follows from the classification of Gly 
as a buried residue in the Janin’s scale, while Gly partitions as if it is polar according to Guy’s 
scale. The AMP-Designer algorithm, with a flexible choice of screening criteria, will be 
useful help in exploring a broad range of helix-type peptide antibiotics, which biological 
evolution has left unexplored. 
The concept and the algorithm used to design DESC1 are also likely to be useful tools 
for redesign and selectivity optimization of existing helix-type AMPs. The separation of 
sequence moments is such a sensitive descriptor that it can predict large TI increase even after 
a single point mutation. One example is the correct prediction of the TI value increase from a 
measured value of 20 (predicted value of 19.6)  for magainin 2,  to a measured value of 125 
(predicted value of 94) for magainin 2 F5W6 (Supplementary Figure S5). This confirms the 
potential usefulness of the D descriptor, when associated with appropriate constraints, for 
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developing and refining new lead compounds with increased selectivity against Gram-
negative bacteria. 
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Methods 
Statistical methods  
We used the correlation between a given descriptor, derived from sequence moments, and the 
measured TI values in the training data set of 36 non-homologous peptides as selection 
criterion. To calculate sequence moments (see Figure 1 legend) we used 144 different scales 
of amino acid attributes, several different procedures for creating sequence profiles s  (see 
main text), 15 peptide bending angles  /15, /14,...,α π π π=  and five pondering values 
1 1 10,1, , ,
2 3 4
q = . From the so obtained sequence moment vectors we have used only those 
pairs of sequence profiles ( )1 2,s s  that corresponded to the same angle and same pondering 
value. One-parameter models were obtained by transforming each ( )1 2,s s  pair into 36 
numbers ( ), , 1 2,i j kd s s  defined by: 
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Note that some of these numbers correspond to one scale only, but with such a choice of 
scalar descriptors the highest correlation with measured TI was 2 0.52r = . Much better results 
are obtained with a triplet defined by choosing two different amino acid scales and one 
smoothing technique. In this way we have assigned 2700 scalar descriptors to each triplet. 
The best correlation between descriptor and observed TI in the training data set is assigned to 
the chosen triplet.  Out of thousands of triplets, only 3 corresponded to correlation coefficients 
2 0.81r ≥  in the training data set.  The sequence moments for these best descriptors were 
obtained by summing all sequence environment vectors i.e. by using the smoothing process 
which excludes the central amino acid in the sliding window (Figure 1).  
 
The simplest descriptor (among 3 best descriptors corresponding to these triplets) was the 
cosine of the angle between sequence moments associated with Janin’s11 and Guy’s12  
hydrophobicity scale, a peptide sequence bending arc of α = π/2 and pondering factor q = 1/3. 
It was named the D  descriptor. It is associated with a correlation 2r  = 0.829 when the 
training data set is used (Supplementary Figure S1). The remaining two descriptors were 
significantly more complex and only one of them was associated with a slightly higher 
correlation coefficient 2 0.838r = . Hence, our choice fell on the D descriptor. (see 
Supplementary Method S1 for one example of the D descriptor calculation). It provides a 
simple method of measuring lengthwise sequence asymmetry in bent peptide sequences. The 
determination coefficient for the test set of peptides was 2R  = 0.64.  This is necessarily lower 
than the correlation between measured TI and D descriptor for those peptides ( 2R  = 0.66) 
(Supplementary Figure S2).  
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We have somewhat misused statistical methods here. Namely, the data in both the training set 
and in the testing set are not normally distributed. Hence, standard statistical practice would 
be not to use Pearson r  correlation, but to use a non-parametric methods instead. However, 
we are not interested in an index that correctly orders peptides according to their TI, but to 
find an index that well predicts which peptides have a very high value of TI. It can be easily 
shown that a given percent error in predicting peptides with high values of TI much more 
influences the Pearson correlation coefficient then the same percent error in predicting 
peptides with the low values of TI. Therefore, r  extracts information which is significant to 
our study.  
 
We addressed also the concern that a small number of peptides with high measured TI in the 
training data set (11 peptides with 20TI ≥ ) are examined by selecting one among millions of 
descriptors. In order to verify that our predictions are not purely casual, we performed the 
same computation, but for each of the amino acid scales we have randomly permuted the data. 
In three such experiments the best values of 2r  have been: 0.71, 0.63 and 0.65, and only very 
few descriptors had comparable values. These are significantly lower than in our calculations 
with correct distribution of amino acid attribute values for each amino acid scale, where we 
furthermore had over a hundred triplets and more than 200 000 descriptors with 2 0.71r ≥ .  
 
The AMP-Designer algorithm and associated restrictions 
 
The basic idea of the algorithm is to support the design of highly selective frog-type helical 
peptide antibiotics by combining D descriptor based TI prediction with rational 
physicochemical and statistical restrictions based on the structural characteristics of such 
AMPs. 
A first set of applied restrictions are very simple general requirements, such as: 
1) D descriptor predicted TI > than 85 (the maximum predicted TI is 96 in the D descriptor 
model); 
2) peptide net positive charge = 4 or 5 (as most frequent in natural helical AMPs3); 
3) mean hydrophobicity (using the CCS scale, see below14)  = -0.5 to -1.5 (as most often 
found for helical AMPs3). 
4) non-polar residues  A, L, M, V, I, F, W are copmletely separate from polar residues E, 
D, Q, N, G, K, R in a helical wheel projection (limiting design to helix-forming 
amphipathic peptides that have glycine residues in the polar helix face); 
5) no more than 2 identical neighboring amino acids (to avoid trivial cases with long 
segments of identical amino acids that do not occur in natural AMPs); 
6) the three C-terminal amino acids should be the C-terminal residues in at least one good 
natural peptide antibiotic.  
The remaining restrictions have been obtained by statistical analyses of the set of best 
peptides (SBP) ( 20TI ≥ , the first 11 and the first 15 peptides respectively from the AMPad 
database training and testing data sets), and by statistical analyses of the full set of peptides 
(SAP) (all AMPad peptides, Supplementary tables S1 and S2). These restrictions are: 
7) the first amino acid (AA) should be G, because most peptides in SBP start by G; 
8) the second AA should be either L  or I , since most of peptides starting with G  in 
SBP have L  or I on the second position; 
9) residues with the highest amino acid selectivity index associated with SBP peptides 
are E , Q , H , G  and D   (Supplementary Table S3), hence at least 9 such AAs 
should be present in a peptide; 
10)  the successor of each AA should be one of the five most common successors of that 
AA in the SBP data set (Supplementary Table S4); 
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11)  the AA placed at the 4i +  position with respect to any AA (spatially close in an α -
helical conformation) should be one of the five most common successors at distance 
4i +  of that AA in the SBP data set (Supplementary Table S5)  
12) the motif regularity index should be less then 2. This index determines how well the 
designed peptide p  incorporates motifs that are the most common in the structure of 
antimicrobial peptides in the SBP data set (see Supplementary Method S2 and 
Supplementary Tables S4 and S5).  
 
Based on these restrictions, we selected the following peptides out of  8x1029 possible ones:  
GLKGLLGKALKGIGKHIGKAQGC; GLKGLLGKALGEAKGLLGKHKGC; GITQGVLKGIGKHVGKALKGIGC; 
GIGKHVGKALKGLKGLLKGLGEC; GIGKHVGKALKGVKGLLKGLGEC; GIGKHVGKALGELKGLLKGLKGC; 
GIGKHVGKALKGLKGLLKGLGES;  The last peptide, DESC 1, was selected for synthesis and 
characterization. It is unlike any known helical peptide. A suitable name for this novel peptide 
would be adepantin 1, an abbreviation for Automatically Designed Peptide Antibiotic No. 1. 
 
 
Mean hydrophobicity and relative amphipathicity 
 
The global hydrophobicity and the amphipathicity for each synthesized peptide sequence were 
calculated using a hydrophobicity index (Hi) scale derived from the normalized and filtered 
consensus of 163 published scales, that is arbitrarily ranged between maximum values of +10 
for Phe, and -10 for Arg3, 14 .  The hydrophobicity is given as the mean value (H = (∑Hi)/ l ), 
where l  = peptide length. The mean hydrophobic moment (µHmax) was calculated as 
described by Eisenberg et al.7. The relative amphipathicity (µH/µHmax) for each peptides 
was then determined with respect to the value of the maximum hydrophobic moment for a 
perfectly amphipathic, 18-residue peptide composed only of Phe and Arg (µHmax = 6.4 with 
our scale). This relative measure of amphipathicity is less likely to vary according to the scale 
used, than an absolute value. 
 
 
Peptide synthesis, purification and characterization 
 
DESC 1 amide, ascaphin-1 amide (ASC 1) and pseudin-2 amide (PSEU 2) were synthesized 
by Fmoc-solid phase peptide synthesis on a Microwave-enhanced CEM Liberty synthesizer 
using Fmoc-PAL-PEG-PS resin (substitution 0.34 mmol/g). The cleaved/deprotection cocktail 
was trifluoroacetic acid, water and triisopropylsilane (95:2.5:2.5). The crude peptides were 
purified on a preparative Waters XTerra® C18, 7 µm, 300 Å, 19x300 mm column using a 25-
45% CH3CN in 60 min gradient with a 5 ml/min flow. Peptides quality and purity were 
verified by mass spectrometry (Esquire 4000 Ion Trap, Bruker Daltonics Inc, Germany), 
while peptide concentrations were determined by mass and verified by the Waddell method20.   
The capacity of each synthesized peptide to assume a helical conformation was probed by CD 
spectroscopy on a Jasco J-715 spectropolarimeter (Jasco, Japan), using 2 mm path length 
quartz cells and peptide concentrations of 20 µM, in 5 mM sodium phosphate buffer pH7, in 
the absence and presence of 50 % (v/v) TFE. All spectra are the mean of at least two trials, 
each with the accumulation of three scans. Helical content (% Helix) was estimated from the 
molar ellipticity at 222 nm, according to the method of Chen21.  
 
 
Hemolytic activity (HC50) 
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The hemolytic activity of peptides was assessed using freshly isolated human erythrocytes 
from healthy donors, by monitoring the release of hemoglobin at 405 nm. Aliquots of cell 
suspension (0.5% erythrocytes) were incubated in triplicate with different peptide 
concentrations (from 10 µM to 800 µM) in PBS at 37o C for 30 minutes. Total lysis (100% 
hemolysis) was determined by addition of 0.2% Triton X-100. The HC50 value was taken as 
the mean concentration of the peptide producing 50% hemolysis.  
 
 
Antimicrobial activity and therapeutic index determination 
 
The bacteriostatic activity of the peptides was determined against Escherichia coli ATCC 
25922, Pseudomonas aeruginosa ATCC 27853 and Staphylococcus aureus ATCC (105 
cfu/ml bacteria), as minimum inhibitory concentrations (MIC), using the microdilution 
susceptibility test in MH broth as described previously13, or as the effect on bacterial growth 
kinetics (106 cfu/ml bacteria in PBS) in the presence of different peptide concentrations (2, 4 
and 8 µM), monitoring the optical density at 600 nm for 4h. The therapeutic index (TI) is 
defined as the ratio of  HC50/MIC. 
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Figure 1.  Sequence moments for PGLa (left panel) and pseudin 2 (right panel). 
To take into account positional-dependent properties4,6 p , we introduce the peptide sequence 
moment ( )v p  corresponding to sequence profile ( )1,..., lp p p= . ( )v p  is defined as the 
weighted vector sum of ip -vectors associated with each amino acid in a sequence of length 
l when the peptide sequence is bent in an arc α . Pondering of ip -vectors by ( )1 ql i+ − , 
where q  is a constant in the range 0 to 1, models the observation that amino acids closer to 
the N-terminus are more relevant for peptide’s activity3,13. After performing vector 
summation of ( )1 qip l i+ −r terms, the resulting sequence moment x and y coordinates are 
given by:  
( ) ( ) ( ) ( ),
1 1
cos 1 , sin 1
1 1
l l
q q
q i i
i i
l i l iv p v p p l i p l i
l lα
α α
= =
⎛ − − ⎞⎛ ⎞ ⎛ ⎞
= = ⋅ ⋅ ⋅ + − ⋅ ⋅ ⋅ + −⎜ ⎟ ⎜ ⎟⎜ ⎟
− −⎝ ⎠ ⎝ ⎠⎝ ⎠∑ ∑ . 
In this example, we used optimal values / 2α π=   and  q = 1/3 (see Statistical Methods). 
Calculation details can be found in the Supplementary method S1 for the case of PGLa. For 
each residue, small blue arrows are calculated by using Guy’s amino acid index scale12, while 
red arrows are determined by using Janin’s amino acid index scale11. The D descriptor is the 
cosine of the angle between the resulting vector sums of the sequence moments (large arrows) 
for a chosen peptide. Since this descriptor does not take into account the lengths of sequence 
moments it is not important that our pondering function enhances sequence moment length for 
longer peptides. Predicted TI values for PGLa and pseudin 2 are 95 and 8 respectively.  
 
 
Figure 2. Hemolytic activity of DESC 1 ( -●-), ASC 1 (-▲-) and PSEU 2 (-■-). The 
hemolytic activity of the peptides was calculated as percent lysis of human erythrocytes (0.5% 
suspension) with increasing peptide concentrations (from 10 - 800 µM) in PBS, after 
incubation at 37 oC for 30 minutes, and are the mean of two experiments performed in 
triplicate. Total lysis (100% hemolysis) was determined by addition of 0.2% Triton X-100.  
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Table 1. Biological activities and therapeutic index determination 
1  DESC1 = GIGKHVGKALKGLKGLLKGLGES-NH2 , ASC 1 = ascaphin 122 , PSEU 2 = 
pseudin 223.  
2 Carried out in 100 % (v/v) MH broth with 105 CFU/ml bacteria in the logarithmic phase - 
mean of at least three experiments performed in duplicate.  
3 Calculated from % lysis vs concentration plots, see Fig. 2 -  the mean of two experiments 
performed in triplicate. 
4 TI, therapeutic index  
5 Calculated for the indicated concentration of peptide, at the 4th hour, from bacterial 
growth kinetics curves, monitoring OD at 600nm (100% v/v MH broth, 106 CFU/ml 
logarithmic phase bacteria) - mean of two experiments performed in triplicate).  
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5 % bacterial growth inhibition 
(E. coli) 
E. coli P. aeruginosa S. aureus (μM) (HC50/MIC) 2μM 4μM 8μM 
DESC 1 2-4 16 >128 >800 200 10 75 100 
ASC 1 2 16 32 80 39 65 100 100 
PSEU 2 8 >64 32 50 6 0 25 100 
 
